These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21532371)

  • 1. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid.
    Schilling C; Blum WF; Heuser I; Paslakis G; Wudy SA; Deuschle M
    J Clin Psychopharmacol; 2011 Jun; 31(3):390-2. PubMed ID: 21532371
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment.
    Weber-Hamann B; Blum WF; Kratzsch J; Gilles M; Heuser I; Deuschle M
    Pharmacopsychiatry; 2009 Jan; 42(1):23-8. PubMed ID: 19153943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for major depressive disorder: an update.
    Rizvi SJ; Kennedy SH
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):285-94. PubMed ID: 22530790
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression.
    Friedrich M; Grady SE; Wall GC
    Clin Ther; 2010 Jul; 32(7):1221-33. PubMed ID: 20678672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment.
    Carney C
    Depress Anxiety; 1998; 7(4):149-57. PubMed ID: 9706451
    [No Abstract]   [Full Text] [Related]  

  • 6. Switch or augment? Lessons from STAR*D.
    Nierenberg AA
    Ann Clin Psychiatry; 2010 Nov; 22(4 Suppl 3):S4-8. PubMed ID: 21180665
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of depression with melitracen].
    Puzyński S; Kalinowski A
    Wiad Lek; 1967 Oct; 20(20):1859-64. PubMed ID: 4868392
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy.
    Nyhuis PW; Gastpar M; Scherbaum N
    J Clin Psychopharmacol; 2008 Oct; 28(5):593-5. PubMed ID: 18794671
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy, tolerability, and safety of contemporary antidepressants.
    Papakostas GI
    J Clin Psychiatry; 2010; 71 Suppl E1():e03. PubMed ID: 20371030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine.
    Ikenouchi-Sugita A; Yoshimura R; Hori H; Umene-Nakano W; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1451-3. PubMed ID: 19664676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying patients with therapy-resistant depression by using factor analysis.
    Andreasson K; Liest V; Lunde M; Martiny K; Unden M; Dissing S; Bech P
    Pharmacopsychiatry; 2010 Nov; 43(7):252-6. PubMed ID: 20821367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants in bipolar depression: when less is more.
    Ruzickova M; Alda M
    J Psychiatry Neurosci; 2002 Jul; 27(4):312. PubMed ID: 12174738
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.
    Papakostas GI
    Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with butriptyline (AY-62014) in the treatment of depressions.
    González M; Montaño H
    J Med; 1971; 2(5):296-9. PubMed ID: 4948364
    [No Abstract]   [Full Text] [Related]  

  • 16. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyprolidol and imipramine: a double-blind controlled study in endogenous depression.
    Hekimian LJ; Gershon S; Floyd A
    Arzneimittelforschung; 1969 Jun; 19(6):955-6. PubMed ID: 4896165
    [No Abstract]   [Full Text] [Related]  

  • 18. Subjective effects of antidepressants: a pilot study of the varieties of antidepressant-induced experiences in meditators.
    Bitner R; Hillman L; Victor B; Walsh R
    J Nerv Ment Dis; 2003 Oct; 191(10):660-7. PubMed ID: 14555868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of treatment of depressive states with melitracen].
    Madejska N; Mika M; Pańkow T
    Psychiatr Pol; 1967; 1(4):463-71. PubMed ID: 5595168
    [No Abstract]   [Full Text] [Related]  

  • 20. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.